...
首页> 外文期刊>Journal of the Iranian Chemical Society >Synthesis of piperazine based N-Mannich bases of berberine and their antioxidant and anticancer evaluations
【24h】

Synthesis of piperazine based N-Mannich bases of berberine and their antioxidant and anticancer evaluations

机译:基于哌嗪的小ber碱N-曼尼希碱的合成及其抗氧化和抗癌性评估

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Isoquinoline alkaloids possess versatile biological activities. Hence, in the current research an effort has been made to improve structurally important part of isoquinoline alkaloid berberine because it is recognized as the marking compound for the crude drugs. Synthesis of rationalized berberine has been performed via substituting various piperazine moieties bearing disubstituted electron withdrawing and electron donating groups to the berberine core via Mannich reaction. Intended scaffolds were inspected for their in vitro antioxidant potential using different bioassays, FRAP, DPPH and ABTS as well as anticancer efficacies against cervical cancer cell lines HeLa, CaSki adapting SRB assay. Also, an inspection of the cytotoxic nature of titled analogues has been carried out towards Madin-Darby canine kidney (MDCK) cell lines. Radical scavenging potential of the final derivatives 4a-i was found to be excellent with IC50s, <20 and <12 mu g/mL in DPPH and ABTS assay, respectively, whereas some dichlorophenyl piperazine analogues revealed important Fe3+ decreasing power with absorption at around 2 nm in FRAP assay. Moreover, compounds 4a-i appeared with significant inhibitors of the cervical cancer cell lines HeLa and CaSki with IC50s ranging 4.346-6.321 and 3.408-6.081 mu g/mL, with low level of cytotoxic values and higher therapeutic indices ranging 20.42-42.45 and 21.23-43.25, respectively. Therefore, from the bioassay results it can be mentioned that these analogues are effective double agents as the scavengers of reactive oxygen species and inhibitors of the cancerous cells. The correct structure of the final compounds was adequately confirmed on the basis of FT-IR, H-1 NMR and mass spectroscopy data as well as elemental analyses.
机译:异喹啉生物碱具有多种生物活性。因此,在当前的研究中,已经努力改善异喹啉生物碱小ber碱的结构上重要的部分,因为它被认为是粗药物的标记化合物。合成合理的小ber碱的方法是,通过曼尼希反应将各种带有双取代的吸电子基团和给电子基团的哌嗪部分取代至小ber碱核心。使用不同的生物测定法,FRAP,DPPH和ABTS检查目标支架的体外抗氧化能力,以及适应SRB试验的针对宫颈癌细胞系HeLa,CaSki的抗癌作用。而且,已经对麦丁达比犬肾(MDCK)细胞系进行了标题类似物的细胞毒性性质的检查。发现最终衍生物4a-i的自由基清除能力在DP50和ABTS分析中的IC50s分别为<20和<12μg/ mL时极佳,而一些二氯苯基哌嗪类似物显示出重要的Fe3 +降低功率,吸收在2左右FRAP分析中的nm。此外,化合物4a-i与宫颈癌细胞系HeLa和CaSki的重要抑制剂一起出现,IC50范围为4.346-6.321和3.408-6.081μg / mL,具有较低的细胞毒性值和较高的治疗指数,范围为20.42-42.45和21.23。 -43.25分别因此,从生物测定结果中可以提及,这些类似物是有效的双重试剂,作为活性氧的清除剂和癌细胞的抑制剂。根据FT-IR,H-1 NMR和质谱数据以及元素分析,可以充分确认最终化合物的正确结构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号